Smouldering multiple sclerosis: the 'real MS'

G Giovannoni, V Popescu, J Wuerfel… - Therapeutic …, 2022 - journals.sagepub.com
Using a philosophical approach or deductive reasoning, we challenge the dominant clinico-
radiological worldview that defines multiple sclerosis (MS) as a focal inflammatory disease …

Seeking heterocyclic scaffolds as antivirals against dengue virus

S De, B Aamna, R Sahu, S Parida, SK Behera… - European Journal of …, 2022 - Elsevier
Dengue is one of the most typical viral infection categorized in the Neglected Tropical
Diseases (NTDs). It is transmitted via the female Aedes aegypti mosquito to humans and …

Twenty years of equine piroplasmosis research: global distribution, molecular diagnosis, and phylogeny

S Tirosh-Levy, Y Gottlieb, LM Fry, DP Knowles… - Pathogens, 2020 - mdpi.com
Equine piroplasmosis (EP), caused by the hemoparasites Theileria equi, Theileria haneyi,
and Babesia caballi, is an important tick-borne disease of equines that is prevalent in most …

Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives

L Zhang, J Zhang, J Wang, C Ren, P Tang… - European journal of …, 2022 - Elsevier
Human dihydroorotate dehydrogenase (hDHODH) is a flavin-dependent enzyme catalyzing
the fourth step of pyrimidine de novo biosynthesis. Since aberrant pyrimidine metabolism is …

Recent advances on patents of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors as antimalarial agents

P Gehlot, VK Vyas - Expert Opinion on Therapeutic Patents, 2023 - Taylor & Francis
Introduction Pyrimidine nucleotides are essential for the parasite's growth and replication.
Parasites have only a de novo pathway for the biosynthesis of pyrimidine nucleotides …

Novel promising antifungal target proteins for conquering invasive fungal infections

C Zhen, H Lu, Y Jiang - Frontiers in microbiology, 2022 - frontiersin.org
Invasive fungal infections (IFIs) pose a serious clinical problem, but the antifungal arsenal is
limited and has many disadvantages, such as drug resistance and toxicity. Hence, there is …

Potential anti-SARS-CoV-2 therapeutics that target the post-entry stages of the viral life cycle: A comprehensive review

RA Al-Horani, S Kar - Viruses, 2020 - mdpi.com
The coronavirus disease-2019 (COVID-19) pandemic continues to challenge health care
systems around the world. Scientists and pharmaceutical companies have promptly …

Exploring marine-derived ascochlorins as novel human dihydroorotate dehydrogenase inhibitors for treatment of triple-negative breast cancer

X Luo, G Cai, Y Guo, C Gao, W Huang… - Journal of Medicinal …, 2021 - ACS Publications
Human dihydroorotate dehydrogenase (h DHODH) is an attractive tumor target essential to
de novo pyrimidine biosynthesis. Novel potent h DHODH inhibitors with low toxicity are …

Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review

RD Alamri, MA Elmeligy, GA Albalawi… - International …, 2021 - Elsevier
Leflunomide (LF) represents the prototype member of dihydroorotate dehydrogenase
(DHODH) enzyme inhibitors. DHODH is a mitochondrial inner membrane enzyme …

Identification of dihydroorotate dehydrogenase inhibitors using the cell painting assay

B Schölermann, J Bonowski, M Grigalunas… - …, 2022 - Wiley Online Library
Profiling approaches have been increasingly employed for the characterization of disease‐
relevant phenotypes or compound perturbation as they provide a broad, unbiased view on …